MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease
The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.